Clinipace Worldwide, which recently raised $9 million in additional funding, used some of that money to fuel the launch of a new cloud-computing-based service on Tuesday.
Morrisville-based Clinipace launched an eclinical trials service platform called Tempo to link teams over the cloud to “one platform, one database.”
Chief Executive Officer Jeff Williams disclosed the new service at the JP Morgan Healthcare Conference.
Clinipace says the new service will help clients:
- Improve study visibility
- Control deliverables and documents
- Reduce costs from start-up to close-out
- Replace multiple disparate technologies/bolt-on apps
The product also includes a trial manager and configurable modules for work forms, reports and other documents.
“The ability to provide cross-function and cross-trial management and visibility without excessive and expensive IT infrastructure is a huge benefit to our clients and a significant differentiator for the company,” said Daryl Porter, the chief technology officer at Clinipace.
“As an example, we’ve created new software tools and related methods called Just-In-Time Monitoring to enhance our team’s ability to perform more risk-based monitoring, which has the potential to dramatically change the way we interact with our investigator sites and perform monitoring activities. With Just-In-Time Monitoring, activities are driven by data and analytics derived from actual site enrollment and behavior, not a generic static plan that relies exclusively on the site visit. By combining this increased level of information and analysis with experienced project leadership and CRAs we’re able to deliver superior performance and quality.”